Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice
- PMID: 7515187
- PMCID: PMC43947
- DOI: 10.1073/pnas.91.11.5138
Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice
Abstract
Tolerance to peripheral antigens is thought to result from the inability of parenchymal tissue to stimulate T cells--an inability that is believed to relate to the lack of expression of the costimulatory signal(s) required for T-cell activation. To test this model, we generated transgenic mice expressing costimulatory molecule B7-1 on the B cells of the pancreas. We find that islets from these transgenic mice are immunogenic for naive T cells in vitro and in vivo. Nonetheless, mice expressing the costimulator B7-1 specifically on beta cells do not develop diabetes, suggesting that expression of the B7-1 costimulator is not sufficient to abrogate the tolerance to peripheral antigens. We have reported that tumor necrosis factor alpha subunit (TNF-alpha) expressed by beta cells leads to a local inflammation but no islet destruction. Strikingly, however, the combination of a local inflammation due to the expression of the cytokine TNF-alpha and the expression of B7-1 results in tissue destruction and diabetes.
Similar articles
-
The role of the T cell costimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen.Immunity. 1994 May;1(2):155-66. doi: 10.1016/1074-7613(94)90109-0. Immunity. 1994. PMID: 7534199
-
Preservation of beta-cell function during immune-mediated, B7-1-dependent alpha-cell destruction.Eur J Immunol. 2005 Sep;35(9):2583-90. doi: 10.1002/eji.200525978. Eur J Immunol. 2005. PMID: 16078275
-
Expression of the B7.1 costimulatory molecule on pancreatic beta cells abrogates the requirement for CD4 T cells in the development of type 1 diabetes.J Immunol. 2004 Jul 15;173(2):787-96. doi: 10.4049/jimmunol.173.2.787. J Immunol. 2004. PMID: 15240665
-
T-cell receptor-transgenic NOD mice: a reductionist approach to understand autoimmune diabetes.J Autoimmun. 2004 Mar;22(2):121-9. doi: 10.1016/j.jaut.2003.10.003. J Autoimmun. 2004. PMID: 14987740 Review. No abstract available.
-
A new view of the beta cell as an antigen-presenting cell and immunogenic target.J Autoimmun. 1990 Apr;3 Suppl 1:53-62. doi: 10.1016/s0896-8411(09)90010-5. J Autoimmun. 1990. PMID: 1971174 Review.
Cited by
-
What can the HLA transgenic mouse tell us about autoimmune diabetes?Diabetologia. 2004 Sep;47(9):1476-87. doi: 10.1007/s00125-004-1505-5. Epub 2004 Sep 2. Diabetologia. 2004. PMID: 15349728 Review.
-
Increased programmed death-ligand-1 expression in human gastric epithelial cells in Helicobacter pylori infection.Clin Exp Immunol. 2010 Sep;161(3):551-9. doi: 10.1111/j.1365-2249.2010.04217.x. Clin Exp Immunol. 2010. PMID: 20646001 Free PMC article.
-
Manipulating the type 1 vs type 2 balance in type 1 diabetes.Immunol Res. 2004;30(3):309-25. doi: 10.1385/IR:30:3:309. Immunol Res. 2004. PMID: 15531772 Review.
-
Lymphotoxin and TNF: how it all began-a tribute to the travelers.Cytokine Growth Factor Rev. 2014 Apr;25(2):83-9. doi: 10.1016/j.cytogfr.2014.02.001. Epub 2014 Feb 12. Cytokine Growth Factor Rev. 2014. PMID: 24636534 Free PMC article. Review.
-
Cyclin D3 promotes pancreatic β-cell fitness and viability in a cell cycle-independent manner and is targeted in autoimmune diabetes.Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):E3405-14. doi: 10.1073/pnas.1323236111. Epub 2014 Aug 4. Proc Natl Acad Sci U S A. 2014. PMID: 25092329 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials